Anbio Biotechnology: xbrl:IncreaseDecreaseInAccountsPayable

Value{"amount": -580891, "currency": "USD"}
Period2023-01-01 – 2023-12-31
Statuscurrent
EntityAnbio Biotechnology
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001213900-25-035802
Retrieved: 2026-08-19T19:02:33.643442+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Cite as: FACTANKER, https://factanker.com/fact/b2548923-c244-41e6-8667-f3b2faa6b2b9

History